Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal Infection

Exclusion Criteria

• •Evidence of any clinically significant liver or renal function or other abnormalities such as cardiac arrhythmia, hypokalemia, hypomagnesemia or hypocalcemia.
• •Documented bacterial or viral infection not responding to appropriate treatment.
• •Hypersensitivity to or severe intolerance of azole antifungal agents.
• •Receiving other azoles or drugs that is are prohibited in the voriconazole label or associated.